In a move that underscores the growing global emphasis on fortifying regional biopharmaceutical supply chains, Samsung Biologics has finalized a landmark agreement to acquire its first-ever manufacturing facility in the United States. The South Korean-based contract development and manufacturing
In the unseen world of high-performance technology, components operating under extreme heat, intense corrosive forces, and demanding physical stress are what separate mission success from catastrophic failure. A comprehensive analysis detailed in a recent project report for 2026 has provided an
The rapidly accelerating expansion of the 3D-printed medical device market, projected to surge from $678.23 million in 2024 to an impressive $2.62 billion by 2033, represents far more than just technological progress; it signals a fundamental restructuring of the healthcare industry itself. This
What if the next breakthrough in life-saving therapies was just a step away, waiting for the right tools and proximity to become reality? In a world where biopharmaceutical challenges grow more complex by the day, Thermo Fisher Scientific is stepping up with an ambitious expansion of bioprocess
Imagine a world where the smallest particles of metal hold the key to revolutionizing industries, from crafting lightweight aircraft components to designing corrosion-resistant medical implants. This is the reality of the stainless steel powder market, a niche but rapidly expanding segment of the
From Legacy Pills to Precision Platforms: Why Novartis Is Rewiring Its Factories Now A sprawling pivot only makes sense when the old playbook stops working and the new one promises faster launches, steadier supply, and tighter quality for therapies that cannot afford a slip. Manufacturing leaders
